<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-11T21:28:49Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.00zug" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.00zug</identifier>
    <datestamp>2026-08-24T16:28:21Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-08-24</dc:date>
  <dc:title>Analytic Datasets from Randomized Clinical Trial of Baricitinib for Acute Intracerebral Hemorrhage</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.00zug</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>This site provides the analytic datasets for the BRIGHT clinical trial: Baricitinib for Acute Intracerebral Hemorrhage (Trial registration: https://clinicaltrials.gov/study/NCT06737705). The analytic datasets are used for statistical analyses and presented in the results and conclusions of the trial article.&amp;nbsp;Four analytic datasets are available for publication, which include:Subject-level Analysis Dataset: includes an anonymous participant identifier, analytic population flags, the trial group, baseline characteristics, subgroup flags, covariates, and outcomes of each participant. This dataset served for primary analysis.Event-level Analysis Dataset (SAE): includes analytic population flags, the trial group, and the detailed MedDRA category of each serious adverse event. This dataset served for primary analysis.Event-level Analysis Dataset (Immune cell counts): includes analytic population flags, the trial group, the detailed sampling time, and the cell count of each blood test. This dataset served for exploratory analysis.Time-to-event Analysis Dataset: includes analytic population flags, the trial group, changed immune status flags, and the event time of each participant. This dataset served for exploratory analysis.&amp;nbsp;Each analytic dataset includes three sheets:Dataset Appendix &amp;ndash; variable dictionary: explains what this analytic variable represents, including detailed descriptions, variable purposes, variable types, and the meanings corresponding to the codes (categorical variable) for each variableAppendix &amp;ndash; derivation rules: supplements how this analytic variable was derived from the original database, including the corresponding original variable name and derivation formula.&amp;nbsp;</dc:description>
  <dc:subject>Baricitinib; clinical trial; intracerebral hemorrhage; stroke ; immunosuppression</dc:subject>
  <dc:creator>Kang Dezhi</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>